Skip to main content
Log in

Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

Sepsis-induced immunosuppression is postulated to contribute to a heightened risk of nosocomial infection (NI). This prospective, single-center, observational study was conducted to assess whether low monocyte human leukocyte antigen-DR expression (mHLA-DR), proposed as a global biomarker of sepsis immunosuppression, was associated with an increased incidence of NI after septic shock.

Methods

The study included 209 septic shock patients. mHLA-DR was measured by flow cytometry at days (D) 3–4 and 6–9 after the onset of shock. After septic shock, patients were screened daily for NI at four sites (microbiologically documented pulmonary, urinary tract, bloodstream, and catheter-related infections). A competing risk approach was used to evaluate the impact of low mHLA-DR on the incidence of NI.

Results

At D3–4, we obtained measurements in 153 patients. Non-survivors (n = 51) exhibited lower mHLA-DR values expressed as means of fluorescence intensities than survivors (n = 102) (33 vs. 67; p < 0.001). The patients who developed NI (n = 37) exhibited lower mHLA-DR values than those without NI (n = 116) (39 vs. 65; p = 0.008). mHLA-DR ≤54 remained independently associated with NI occurrence after adjustment for clinical parameters (gender, simplified acute physiology score II, sepsis-related organ failure assessment, intubation, and central venous catheterization) with an adjusted hazards ratio (aHR) of 2.52 (95% CI 1.20–5.30); p = 0.02. Similarly, at D6–9, low mHLA-DR (≤57) remained independently associated with NI with an aHR of 2.18 (95% CI 1.04–4.59); p = 0.04.

Conclusions

In septic shock patients, after adjustment with usual clinical confounders (including ventilation and central venous catheterization), persistent low mHLA-DR expression remained independently associated with the development of secondary NI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, Network ft C-R (2003) Current epidemiology of septic shock. The CUB-Réa Network. Am J Respir Crit Care Med 168:165–172

    Article  PubMed  Google Scholar 

  2. Landelle C, Lepape A, Français A, Tognet E, Thizy H, Voirin N, Timsit JF, Monneret G, Vanhems P (2008) Nosocomial infection after septic shock among intensive care unit patients. Infect Control Hosp Epidemiol 29:1054–1065

    Article  PubMed  Google Scholar 

  3. Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26:2078–2086

    Article  CAS  PubMed  Google Scholar 

  4. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63–78

    Article  CAS  PubMed  Google Scholar 

  5. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24:273–287

    Article  CAS  PubMed  Google Scholar 

  6. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150

    Article  CAS  PubMed  Google Scholar 

  7. Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316–321

    CAS  PubMed  Google Scholar 

  8. Pugin J (2007) Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 280:21–27; discussion 27–36, 160–164

    Article  CAS  PubMed  Google Scholar 

  9. Monneret G, Venet F, Pachot A, Lepape A (2008) Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14:64–78

    Article  PubMed  Google Scholar 

  10. Schefold JC, Hasper D, Volk HD, Reinke P (2008) Sepsis: time has come to focus on the later stages. Med Hypotheses 71:203–208

    Article  PubMed  Google Scholar 

  11. Caille V, Chiche JD, Nciri N, Berton C, Gibot S, Boval B, Payen D, Mira JP, Mebazaa A (2004) Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock 22:521–526

    Article  CAS  PubMed  Google Scholar 

  12. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175–1183

    Article  PubMed  Google Scholar 

  13. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204–207

    Article  CAS  PubMed  Google Scholar 

  14. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr (1991) HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 161:639–645

    Article  CAS  PubMed  Google Scholar 

  15. Venet F, Tissot S, Debard AL, Faudot C, Crampé C, Pachot A, Ayala A, Monneret G (2007) Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock. Crit Care Med 35:1910–1917

    Article  CAS  PubMed  Google Scholar 

  16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655

    Article  CAS  PubMed  Google Scholar 

  17. Vanhems P, Lepape A, Savey A, Jambou P, Fabry J (2000) Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival. J Hosp Infect 45:98–106

    Article  CAS  PubMed  Google Scholar 

  18. HELICS (2005) Surveillance of nosocomial infections in intensive care units. http://helics.univ-lyon1.fr/documents/icu_protocol.pdf. Accessed 15 June 2009

  19. Monneret G, Elmenkouri N, Bohe J, Debard AL, Gutowski MC, Bienvenu J, Lepape A (2002) Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock. Clin Chem 48:1589–1592

    CAS  PubMed  Google Scholar 

  20. Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141–1154

    Article  Google Scholar 

  21. Fine J, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509

    Article  Google Scholar 

  22. R Development Core Team (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http://www.R-project.org

  23. Vincent JL (2003) Nosocomial infections in adult intensive-care units. Lancet 361:2068–2077

    Article  PubMed  Google Scholar 

  24. Brawley RL, Weber DJ, Samsa GP, Rutala WA (1989) Multiple nosocomial infections. An incidence study. Am J Epidemiol 130:769–780

    CAS  PubMed  Google Scholar 

  25. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121

    Article  PubMed  Google Scholar 

  26. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218–223

    CAS  PubMed  Google Scholar 

  27. Astiz M, Saha D, Lustbader D, Lin R, Rackow E (1996) Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 128:594–600

    Article  CAS  PubMed  Google Scholar 

  28. Manjuck J, Saha DC, Astiz M, Eales LJ, Rackow EC (2000) Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 135:153–160

    Article  CAS  PubMed  Google Scholar 

  29. Piani A, Hossle JP, Birchler T, Siegrist CA, Heumann D, Davies G, Loeliger S, Seger R, Lauener RP (2000) Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol 30:3140–3146

    Article  CAS  PubMed  Google Scholar 

  30. Satoh A, Miura T, Satoh K, Masamune A, Yamagiwa T, Sakai Y, Shibuya K, Takeda K, Kaku M, Shimosegawa T (2002) Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 25:245–250

    Article  PubMed  Google Scholar 

  31. Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, Camus C, Fauchet R, Thomas R, Drénou B (2004) Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169:1144–1151

    Article  PubMed  Google Scholar 

  32. Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R, Klein NJ (2002) Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30:1140–1145

    Article  PubMed  Google Scholar 

  33. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746–2752

    Article  CAS  PubMed  Google Scholar 

  34. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678–681

    Article  PubMed  Google Scholar 

  35. Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30:1488–1494

    Article  CAS  PubMed  Google Scholar 

  36. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind randomized placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648

    Article  CAS  PubMed  Google Scholar 

  37. Döcke WD, Höflich C, Davis KA, Röttgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, Nebe T, Engel A, Monneret G, Spittler A, Schmolke K, Reinke P, Volk HD, Kunz D (2005) Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 51:2341–2347

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Professor Christian Brun-Buisson, Dr. Raphaele Girard, all the intensivists of the Centre Hospitalier Lyon Sud, CCLIN Sud Est. The study was conducted thanks to the logistic support of Centre d’Investigation Clinique (CIC 201) of INSERM and Hospices Civils de Lyon. Thanks are also due to Ovid Da Silva for editing this manuscript. The present work was supported by Hospices Civils de Lyon. In addition, C. Landelle was funded by Hospices Civils de Lyon and Centre National de la Recherche Scientifique (Contrat d’Assistant Hospitalier de Recherche HCL/CNRS). C. Landelle received the International Sepsis Forum (ISF) Sepsis Award for a part of this work during the joint ESCMID (European Society of Clinical Microbiology and Infectious Disease)/ISF Sepsis Forum on May 2009 at the 19th ECCMID (European Congress of Clinical Microbiology and Infectious Disease) in Helsinki, Finland.

Conflict of interest statement

None of the authors have any financial interests or affiliations with commercial organizations whose products or services are related to the subject matter of this manuscript (i.e., no existing conflicts of interest).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guillaume Monneret.

Additional information

This article is discussed in the editorial available at: doi:10.1007/s00134-010-1965-7.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 181 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Landelle, C., Lepape, A., Voirin, N. et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36, 1859–1866 (2010). https://doi.org/10.1007/s00134-010-1962-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-010-1962-x

Keywords

Navigation